204 related articles for article (PubMed ID: 34108090)
1. Triglyceride-Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End-Stage Renal Disease on Hemodialysis.
Lamprea-Montealegre JA; Katz R; Scharnagl H; Silbernagel G; März W; Drechsler C; Wanner C; de Boer IH
Am J Cardiol; 2021 Aug; 152():63-68. PubMed ID: 34108090
[TBL] [Abstract][Full Text] [Related]
2. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
[TBL] [Abstract][Full Text] [Related]
4. VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins.
Balling M; Afzal S; Varbo A; Langsted A; Davey Smith G; Nordestgaard BG
J Am Coll Cardiol; 2020 Dec; 76(23):2725-2735. PubMed ID: 33272366
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study.
Hussain A; Sun C; Selvin E; Nambi V; Coresh J; Jia X; Ballantyne CM; Hoogeveen RC
Eur J Prev Cardiol; 2022 Mar; 29(2):e53-e64. PubMed ID: 33580780
[TBL] [Abstract][Full Text] [Related]
7. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
8. Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis.
Yiğitoğlu MR; Polat MF; Akçay F; Ari Z; Uyanik BS; Ozilgili HM
Jpn Heart J; 1997 Jan; 38(1):83-9. PubMed ID: 9186284
[TBL] [Abstract][Full Text] [Related]
9. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
Sacks FM; Alaupovic P; Moye LA; Cole TG; Sussex B; Stampfer MJ; Pfeffer MA; Braunwald E
Circulation; 2000 Oct; 102(16):1886-92. PubMed ID: 11034934
[TBL] [Abstract][Full Text] [Related]
10. Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients.
Ikejiri A; Hirano T; Murayama S; Yoshino G; Gushiken N; Hyodo T; Taira T; Adachi M
Metabolism; 2004 Sep; 53(9):1113-7. PubMed ID: 15334369
[TBL] [Abstract][Full Text] [Related]
11. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Chan DC; Watts GF; Nguyen MN; Barrett PH
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
[TBL] [Abstract][Full Text] [Related]
12. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C
Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222
[TBL] [Abstract][Full Text] [Related]
13. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
[TBL] [Abstract][Full Text] [Related]
14. Changes in lipoproteins induced by the remnant kidney tissue or binephrectomy in chronic uremic patients treated by hemodialysis.
Robert D; Jeanmonod R; Favre H; Fruchart JC; Sturzenegger E; Riesen W
Metabolism; 1989 Jun; 38(6):514-21. PubMed ID: 2498613
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
Dallinga-Thie GM; Berk-Planken II; Bootsma AH; Jansen H;
Diabetes Care; 2004 Jun; 27(6):1358-64. PubMed ID: 15161788
[TBL] [Abstract][Full Text] [Related]
16. Relation of First and Total Recurrent Atherosclerotic Cardiovascular Disease Events to Increased Lipoprotein(a) Levels Among Statin Treated Adults With Cardiovascular Disease.
Wong ND; Zhao Y; Sung J; Browne A
Am J Cardiol; 2021 Apr; 145():12-17. PubMed ID: 33454339
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.
Sentí M; Romero R; Pedro-Botet J; Pelegrí A; Nogués X; Rubiés-Prat J
Kidney Int; 1992 May; 41(5):1394-9. PubMed ID: 1614054
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators.
Wanner C; Krane V; Ruf G; März W; Ritz E
Kidney Int Suppl; 1999 Jul; 71():S222-6. PubMed ID: 10412782
[TBL] [Abstract][Full Text] [Related]
19. Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII.
Hirano T; Sakaue T; Misaki A; Murayama S; Takahashi T; Okada K; Takeuchi H; Yoshino G; Adachi M
Kidney Int; 2003 Jun; 63(6):2171-7. PubMed ID: 12753304
[TBL] [Abstract][Full Text] [Related]
20. Effect of diabetes on uremic dyslipidemia.
Kimoto E; Shoji T; Emoto M; Miki T; Tabata T; Okuno Y; Ishimura E; Inaba M; Nishizawa Y
J Atheroscler Thromb; 2002; 9(6):305-13. PubMed ID: 12560592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
